Nieswandt, 2011, Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke., J Thromb Haemost, 9, 92, 10.1111/j.1538-7836.2011.04361.x
Montalescot, 2011, Platelet biology and implications for antiplatelet therapy in atherothrombotic disease., Clin Appl Thromb Hemost, 17, 371, 10.1177/1076029610373366
Angiolillo, 2010, Basic principles of platelet biology and clinical implications., Circ J., 74, 597, 10.1253/circj.CJ-09-0982
Jennings, 2009, Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis., Thromb Haemost, 102, 248
Boudreau, 2014, Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation., Blood, 124, 2173, 10.1182/blood-2014-05-573543
Harkness, 1981, Hazard of platelet transfusion in thrombotic thrombocytopenic purpura., JAMA, 246, 1931, 10.1001/jama.1981.03320170043028
Gottschall, 1981, Thrombotic thrombocytopenic purpura: experience with whole blood exchange transfusion., Semin Thromb Hemost, 7, 25, 10.1055/s-2007-1005066
Ridolfi, 1981, Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature., Medicine (Baltimore), 60, 413, 10.1097/00005792-198111000-00003
Babcock, 1976, Heparin-induced immune thrombocytopenia., N Engl J Med, 295, 237, 10.1056/NEJM197607292950501
Cimo, 1979, Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses., Am J Hematol, 6, 125, 10.1002/ajh.2830060204
Weismann, 1958, Arterial embolism occurring during systemic heparin therapy., AMA Arch Surg, 76, 219, 10.1001/archsurg.1958.01280200041005
Hosler, 2003, Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases., Arch Pathol Lab Med, 127, 834, 10.5858/2003-127-834-TTPAHU
George, 2014, Syndromes of thrombotic microangiopathy., N Engl J Med, 371, 654, 10.1056/NEJMra1312353
Warkentin, 2010, HIT: more than just heparin., Blood, 115, 1664, 10.1182/blood-2009-12-255877
Warkentin, 2011, HIT paradigms and paradoxes., J Thromb Haemost, 9, 105, 10.1111/j.1538-7836.2011.04322.x
Warkentin, 2003, Heparin-induced thrombocytopenia: pathogenesis and management., Br J Haematol, 121, 535, 10.1046/j.1365-2141.2003.04334.x
Buchanan, 1977, Use of homologous platelet survival in differential diagnoses of chronic thrombocytopenia in childhood., Pediatrics, 59, 45, 10.1542/peds.59.1.49
Stoll, 1985, Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia., Blood, 65, 584, 10.1182/blood.V65.3.584.584
Carr, 1986, Efficacy of platelet transfusions in immune thrombocytopenia., Am J Med, 80, 1051, 10.1016/0002-9343(86)90664-9
Salama, 2008, Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia., Thromb Haemost, 100, 762, 10.1160/TH08-06-0418
Spahr, 2008, Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients., Am J Hematol, 83, 122, 10.1002/ajh.21060
Danese, 2009, Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura., Am J Hematol, 84, 631, 10.1002/ajh.21500
Neunert, 2011, The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia., Blood, 117, 4190, 10.1182/blood-2010-08-302984
Kumar, Platelet transfusion: a systematic review of the clinical evidence. [published online ahead of print November 12, 2014]., Transfusion
American Hospitals Association. Fast facts on US hospitals. Available at: www.aha.org/research/rc/stat-studies/fast-facts.shtml. Accessed December 2014
HCUP Data Use Agreement Training. Available at: www.hcup-us.ahrq.gov/team/NationwideDUA.jsp. Accessed December 2014
Localio, 2001, Adjustments for center in multicenter studies: an overview., Ann Intern Med, 135, 112, 10.7326/0003-4819-135-2-200107170-00012
Hicks, 2014, Association between race and age in survival after trauma., JAMA Surg, 149, 642, 10.1001/jamasurg.2014.166
Software MAD. 3M™ APR DRG software. Available at: http://solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software/
Allford, 2003, Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias., Br J Haematol, 120, 556, 10.1046/j.1365-2141.2003.04049.x
Rock, 1998, Laboratory abnormalities in thrombotic thrombocytopenic purpura., Br J Haematol, 103, 1031, 10.1046/j.1365-2141.1998.01080.x
Duffy, 2013, Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura., J Clin Apher, 28, 356
Swisher, 2009, Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura., Transfusion, 49, 873, 10.1111/j.1537-2995.2008.02082.x
Linkins, 2012, Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines., Chest, 141, e495S, 10.1378/chest.11-2303
Greinacher, 2005, Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients., Thromb Haemost, 94, 132
Lewis, 2006, Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia., Chest, 129, 1407, 10.1378/chest.129.6.1407
Hopkins, 2008, Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature., Transfusion, 48, 2128, 10.1111/j.1537-2995.2008.01822.x
Refaai, 2010, Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia., J Thromb Haemost, 8, 1419, 10.1111/j.1538-7836.2010.03861.x
Tun, 2012, A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis., Int J Hematol, 96, 513, 10.1007/s12185-012-1161-3
Cuker, 2012, How I treat heparin-induced thrombocytopenia., Blood, 119, 2209, 10.1182/blood-2011-11-376293
Provan, 2010, International consensus report on the investigation and management of primary immune thrombocytopenia., Blood, 115, 168, 10.1182/blood-2009-06-225565
Blanchette, 2003, Childhood acute immune thrombocytopenic purpura: 20 years later., Semin Thromb Hemost, 29, 605, 10.1055/s-2004-815628
De Mattia, 2010, Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines., Acta Haematol, 123, 96, 10.1159/000268855
Rodeghiero, 2009, Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group., Blood, 113, 2386, 10.1182/blood-2008-07-162503
British Committee for Standards in Haematology General Haematology Task Force, 2003, Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy., Br J Haematol, 120, 574, 10.1046/j.1365-2141.2003.04131.x
Kawano, 2013, Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection., J Clin Exp Hematop, 53, 151, 10.3960/jslrt.53.151
Heckbert, 2004, Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative., Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314
Health Cost and Utilization Project Quality Control Procedures Available at: www.ahrq.gov/data/hcup/sasddocu/techsupp2.pdf. Accessed December 2014
Comparative Analysis of HCUP and NHDS Inpatient Discharge Data Available at: www.ahrq.gov/data/hcup/nhds/niscomp.htm
George, 2013, The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care., Hamostaseologie, 33, 105, 10.5482/HAMO-12-10-0016
Wahl, 2012, Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States., Transfusion, 52, 1614, 10.1111/j.1537-2995.2012.03758.x